心力衰竭与心房颤动对缺血性卒中结局的独立与联合影响
结果显示房颤和心衰均独立增加院内死亡和长期死亡风险,二者合并时风险最高;房颤相关卒中复发风险独立于心衰,而无房颤的心衰亦与复发风险显著相关。
要点
- 房颤和心衰均独立增加急性缺血性卒中院内死亡风险,二者合并时风险最高。
- 房颤、心衰及其组合均与长期死亡风险增加相关,组合风险最高。
- 房颤相关卒中复发风险独立于心衰,无房颤的心衰亦与复发风险显著相关。
核心结论
- 房颤相关卒中复发风险独立于合并心衰。
- 无房颤的心衰亦与显著卒中复发风险相关。
- 无房颤心衰患者二级预防抗凝可能需临床试验进一步评估。
研究设计与样本
- 前瞻性队列研究,纳入2004至2016年英国一家中心收治的急性缺血性卒中患者,覆盖约90万人口。
- 暴露分组:无房颤无心衰(参照组)、有房颤无心力衰竭、有心衰无房颤、房颤合并心衰。
- 采用逻辑回归和Cox回归分别建模院内和长期结局。
主要发现
- 院内死亡:房颤OR 1.24(95%CI 1.07-1.43),心衰OR 1.40(1.10-1.79),二者合并OR 2.23(1.83-2.72)。
- 三个暴露组均与住院时长增加相关,仅房颤预测残疾增加(1.36 [1.12-1.64])。
- 长期死亡随访中位5.5年:房颤HR 1.45(1.33-1.59),心衰HR 2.07(1.83-2.36),合并HR 2.20(1.96-2.46)。
- 卒中复发随访中位3.7年:房颤HR 1.50(1.26-1.78),心衰HR 1.33(1.01-1.75),合并HR 1.62(1.28-2.07)。
- 无房颤的心衰患者出院时仅30例(4.9%)接受抗凝治疗。
临床怎么用
- 对急性缺血性卒中患者应评估房颤和心衰,二者并存时院内死亡和长期死亡风险最高。
- 无房颤的心衰患者卒中复发风险显著,需关注二级预防策略,但抗凝决策待临床试验评估。
局限性
- 研究为单中心前瞻性队列,外推性需谨慎。
- 无房颤心衰患者出院抗凝比例极低(4.9%),可能影响复发风险解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- We aimed to determine individual and combined effects of atrial fibrillation (AF) and heart failure (HF) on acute ischemic stroke outcomes: in-hospital mortality, length-of-stay, and poststroke disability; long-term mortality and stroke recurrence. Methods- Prospective cohort study of patients with acute ischemic stroke admitted to a UK center with a catchment population of ≈900 000 between 2004 and 2016. Exposure groups were patients with neither AF nor HF (reference group), those with AF but without HF, those with HF but without AF, and those with AF+HF. Logistic and Cox regressions were used to model in-hospital and long-term outcomes, respectively. Results- A total of 10 816 patients with a mean age±SD =77.9±12.1 years, 48% male were included. Only 30 (4.9%) of the patients with HF but not AF were anticoagulated at discharge. Both AF (odds ratio, 1.24 [95% CI, 1.07-1.43]), HF (odds ratio, 1.40 [1.10-1.79]), and their combination (odds ratio, 2.23 [1.83-2.72]) were associated with increased odds of in-hospital mortality. All 3 exposure groups were associated with increased length-of-stay, while only AF predicted increased disability (1.36 [1.12-1.64]). Patients were followed for a median of 5.5 and 3.7 years for mortality and recurrence, respectively. Long-term mortality was associated with AF (hazard ratio, 1.45 [95% CI, 1.33-1.59]), HF (2.07 [1.83-2.36]), and their combination (2.20 [1.96-2.46]). Recurrent stroke was associated with AF 1.50 (1.26-1.78), HF (1.33 [1.01-1.75]), and AF with HF (1.62 [1.28-2.07]). Conclusions- The AF-associated excess risk of stroke recurrence was independent of comorbid HF. HF without AF was also associated with a significant risk of recurrence. Anticoagulation for secondary stroke prevention in patients with HF without AF may require further evaluation in a clinical trial setting.
引用
- Pana TA, McLernon DJ, Mamas MA, et al. Individual and Combined Impact of Heart Failure and Atrial Fibrillation on Ischemic Stroke Outcomes. Stroke. 2019. PMID: 31154943. doi:10.1161/STROKEAHA.119.025481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。